Long-term therapy-free remission in a patient with platelet-derived growth factor receptor beta-rearranged myeloproliferative neoplasm

Am J Hematol. 2016 Sep;91(9):E353. doi: 10.1002/ajh.24422. Epub 2016 Jun 20.

Authors

Marco Cerrano¹, Elena Crisà¹, Enrico Gottardi², Chiara Aguzzi¹, Mario Boccadoro¹, Dario Ferrero¹

Affiliations

¹ Hematology Division, Università Degli Studi Di Torino, Turin, Italy.
² AOU San Luigi Gonzaga, SCDU Internal Medicine II, Orbassano, Italy.

PMID: 27194679
DOI: 10.1002/ajh.24422

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / therapeutic use
ETS Translocation Variant 6 Protein
Gene Rearrangement*
Humans
Imatinib Mesylate / therapeutic use
Male
Middle Aged
Myeloproliferative Disorders / diagnosis*
Myeloproliferative Disorders / drug therapy
Myeloproliferative Disorders / genetics*
Protein Kinase Inhibitors / therapeutic use
Proto-Oncogene Proteins c-ets / genetics
Receptor, Platelet-Derived Growth Factor beta / genetics*
Remission Induction
Repressor Proteins / genetics
Treatment Outcome

Substances

Antineoplastic Agents
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-ets
Repressor Proteins
Imatinib Mesylate
Receptor, Platelet-Derived Growth Factor beta